Financhill
Back

Silence Therapeutics Plc Stock Predictions

Silence Therapeutics Plc Stock Forecast

  • Is Silence Therapeutics Plc Stock Undervalued?
    The current Silence Therapeutics Plc [SLNCF] share price is $1.60. The Score for SLNCF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • SLNCF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Silence Therapeutics Plc Stock Go Up Next Year?

Data Unavailable

Silence Therapeutics Plc Stock Rating

Data Unavailable

Silence Therapeutics Plc Stock Price History

Is SLNCF stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SLNCF is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
United Kingdom
Industry:
Sector:
Type:
stock
Website:
silence-therapeutics.com

52-Week Data

52-Week High:
2.25
52-Week Low:
0.50

Prediction Charts

Market Cap:
226.7M
Price in USD:
1.60
Volume:
0
Beta:
2.46

Technical Analysis

SMA50:
1.68
SMA100:
1.66
SMA200:
1.56
52-Wk Change:
6.67%

Stock Predictions

  • Is Silence Therapeutics Plc stock public?
    Yes, Silence Therapeutics Plc is a publicly traded company.
  • What is the Silence Therapeutics Plc stock quote today?
    The Silence Therapeutics Plc stock price is 1.60 USD today.
  • How to buy Silence Therapeutics Plc stock online?
    You can buy Silence Therapeutics Plc shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-23 1.50 1.50 1.50 1.50
Jan-26 1.50 1.50 1.50 1.50
Jan-27 1.60 1.60 1.60 1.60
Jan-28 1.60 1.60 1.60 1.60
Jan-29 1.60 1.60 1.60 1.60
Jan-30 1.60 1.60 1.60 1.60
Feb-2 1.60 1.60 1.60 1.60
Feb-3 1.60 1.60 1.60 1.60
Feb-4 1.60 1.60 1.60 1.60
Feb-5 1.60 1.60 1.60 1.60
Feb-6 1.60 1.60 1.60 1.60
Feb-9 1.60 1.60 1.60 1.60
Feb-10 1.60 1.60 1.60 1.60
Feb-11 1.60 1.60 1.60 1.60

Silence Therapeutics Plc Earnings

Data Unavailable

Silence Therapeutics Plc Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $0.00 per share.

* Silence Therapeutics Plc stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.